782 related articles for article (PubMed ID: 16222725)
1. Enantiomeric 1,2,4-trioxanes display equivalent in vitro antimalarial activity versus Plasmodium falciparum malaria parasites: implications for the molecular mechanism of action of the artemisinins.
O'Neill PM; Rawe SL; Borstnik K; Miller A; Ward SA; Bray PG; Davies J; Oh CH; Posner GH
Chembiochem; 2005 Nov; 6(11):2048-54. PubMed ID: 16222725
[TBL] [Abstract][Full Text] [Related]
2. Novel bis- and tris-1,2,4-trioxanes: synthesis and antimalarial activity against multidrug-resistant Plasmodium yoelii in Swiss mice.
Singh C; Verma VP; Naikade NK; Singh AS; Hassam M; Puri SK
J Med Chem; 2008 Dec; 51(23):7581-92. PubMed ID: 19006381
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, derivatization, and structure-activity relationships of simplified, tricyclic, 1,2,4-trioxane alcohol analogues of the antimalarial artemisinin.
Cumming JN; Wang D; Park SB; Shapiro TA; Posner GH
J Med Chem; 1998 Mar; 41(6):952-64. PubMed ID: 9526569
[TBL] [Abstract][Full Text] [Related]
4. Trioxaferroquines as new hybrid antimalarial drugs.
Bellot F; Coslédan F; Vendier L; Brocard J; Meunier B; Robert A
J Med Chem; 2010 May; 53(10):4103-9. PubMed ID: 20443628
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of antimalarial drug action by chlorpheniramine against multidrug-resistant Plasmodium falciparum in vitro.
Nakornchai S; Konthiang P
Parasitol Int; 2006 Sep; 55(3):195-9. PubMed ID: 16750932
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of artemisone compared with artesunate against Plasmodium falciparum.
Ramharter M; Burkhardt D; Nemeth J; Adegnika AA; Kremsner PG
Am J Trop Med Hyg; 2006 Oct; 75(4):637-9. PubMed ID: 17038685
[TBL] [Abstract][Full Text] [Related]
7. Antimalarial activities of (+)-deoxoartemisitene and its novel C-11, 13 derivatives.
Jung M; Lee K; Jung H; Kendrick H; Yardley V; Croft SL
Bioorg Med Chem Lett; 2004 Apr; 14(8):2001-3. PubMed ID: 15050646
[TBL] [Abstract][Full Text] [Related]
8. Novel spiroanellated 1,2,4-trioxanes with high in vitro antimalarial activities.
Griesbeck AG; El-Idreesy TT; Höinck LO; Lex J; Brun R
Bioorg Med Chem Lett; 2005 Feb; 15(3):595-7. PubMed ID: 15664819
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and Biological Evaluation of Novel 1,2,4-Trioxanes as Potential Antimalarial Agents.
Gupta AK; Varshney K; Kumar V; Srivastava K; Pant AB; Puri SK; Saxena AK
Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28207169
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of extraordinarily potent C-10 carba artemisinin dimers against P. falciparum malaria parasites and HL-60 cancer cells.
Chadwick J; Mercer AE; Park BK; Cosstick R; O'Neill PM
Bioorg Med Chem; 2009 Feb; 17(3):1325-38. PubMed ID: 19136263
[TBL] [Abstract][Full Text] [Related]
11. Orally active 1,2,4-trioxanes: synthesis and antimalarial assessment of a new series of 9-functionalized 3-(1-arylvinyl)-1,2,5-trioxaspiro[5.5]undecanes against multi-drug-resistant plasmodium yoelii nigeriensis in mice.
Singh C; Malik H; Puri SK
J Med Chem; 2006 May; 49(9):2794-803. PubMed ID: 16640340
[TBL] [Abstract][Full Text] [Related]
12. Rationale design of biotinylated antimalarial endoperoxide carbon centered radical prodrugs for applications in proteomics.
Barton V; Ward SA; Chadwick J; Hill A; O'Neill PM
J Med Chem; 2010 Jun; 53(11):4555-9. PubMed ID: 20476788
[TBL] [Abstract][Full Text] [Related]
13. Modular synthesis and in vitro and in vivo antimalarial assessment of C-10 pyrrole mannich base derivatives of artemisinin.
Pacorel B; Leung SC; Stachulski AV; Davies J; Vivas L; Lander H; Ward SA; Kaiser M; Brun R; O'Neill PM
J Med Chem; 2010 Jan; 53(2):633-40. PubMed ID: 19957999
[TBL] [Abstract][Full Text] [Related]
14. In vitro efficiency of new acridyl derivatives against Plasmodium falciparum.
Guetzoyan L; Ramiandrasoa F; Dorizon H; Desprez C; Bridoux A; Rogier C; Pradines B; Perrée-Fauvet M
Bioorg Med Chem; 2007 May; 15(9):3278-89. PubMed ID: 17339112
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, in vitro and in vivo antimalarial assessment of sulfide, sulfone and vinyl amide-substituted 1,2,4-trioxanes prepared via thiol-olefin co-oxygenation (TOCO) of allylic alcohols.
Amewu R; Gibbons P; Mukhtar A; Stachulski AV; Ward SA; Hall C; Rimmer K; Davies J; Vivas L; Bacsa J; Mercer AE; Nixon G; Stocks PA; O'Neill PM
Org Biomol Chem; 2010 May; 8(9):2068-77. PubMed ID: 20401383
[TBL] [Abstract][Full Text] [Related]
16. Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffold.
Rudrapal M; Chetia D
Drug Des Devel Ther; 2016; 10():3575-3590. PubMed ID: 27843298
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antimalarial activity of ethylene glycol oligomeric ethers of artemisinin.
Steyn M; N'Da DD; Breytenbach JC; Smith PJ; Meredith S; Breytenbach WJ
J Pharm Pharmacol; 2011 Feb; 63(2):278-86. PubMed ID: 21235593
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of N1-arylidene-N2-quinolyl- and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains.
Gemma S; Kukreja G; Fattorusso C; Persico M; Romano MP; Altarelli M; Savini L; Campiani G; Fattorusso E; Basilico N; Taramelli D; Yardley V; Butini S
Bioorg Med Chem Lett; 2006 Oct; 16(20):5384-8. PubMed ID: 16890433
[TBL] [Abstract][Full Text] [Related]
19. Novel series of 1,2,4-trioxane derivatives as antimalarial agents.
Rudrapal M; Chetia D; Singh V
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1159-1173. PubMed ID: 28870093
[TBL] [Abstract][Full Text] [Related]
20. Pharmacophore modeling of substituted 1,2,4-Trioxanes for quantitative prediction of their antimalarial activity.
Gupta AK; Chakroborty S; Srivastava K; Puri SK; Saxena AK
J Chem Inf Model; 2010 Aug; 50(8):1510-20. PubMed ID: 20726605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]